Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Demet Cekdemir"'
Autor:
Demet Cekdemir, Mehmet Gunduz, Arzu Celebi, Hale Aslantas, Gokhan Pekındıl, Semin Ayhan, Ender Ellidokuz
Publikováno v:
Ankara Medical Journal, Vol 19, Iss 1, Pp 123-132 (2019)
Amaç: Non-alkolik basit hepatik steatoz hastalarını karaciğer enzim düzeylerine göre karşılaştırmak ve glikoz metabolizması ve insülin direncinin karaciğer enzim düzeyleri ile farklılık gösterip göstermediğini saptamak. Materyal v
Externí odkaz:
https://doaj.org/article/dec7168a12164f3f99e84465a7ae24f2
Autor:
Hasan Ergenc, Demet Cekdemir, Ayse Ceyda Oren, Ali Tamer, Ertuğrul Guclu, Umit Ozcelik, Fatma Dirican, Oguz Karabay, Aziz Ogutlu
Publikováno v:
Sakarya Tıp Dergisi, Vol 8, Iss 3, Pp 632-637 (2018)
Objective: Screening test results of the donors/ patients who applied to Blood Transfusion Center of Sakarya University Training and Research Hospital were retrospectively evaluated.Methods: A total of 13536 donors/patients who applied to our Blood T
Externí odkaz:
https://doaj.org/article/8fe1d05c811044fba6bc6e7b20be59de
Publikováno v:
Clinical Laboratory. 68
Considerable progress has been made in the treatment of multiple myeloma (MM) patients with the development of various new agents that increased survival rates over the past fifteen years. Cereblon (CRBN) plays an important role in mediating the anti
Autor:
Serap Kural, Zafer Gulbas, Ferda Korkmaz, Demet Cekdemir, Yesim Ozgurel, Neslihan Tiryaki, Hasan Atilla Ozkan
Publikováno v:
Clinical Laboratory. 67
BACKGROUND Guillain-Barre Syndrome (GBS) is an acute inflammatory polyneuropathy characterized with rapid, progressive, ascending, and symmetrical weakness and areflexia. It is supposed to be an autoimmune disease related with production of antibodie
Publikováno v:
Nephrology Dialysis Transplantation. 33:i17-i17
Publikováno v:
Nephrology Dialysis Transplantation. 33:i25-i25
Autor:
Anıl Tombak, Funda Pepedil Tanrıkulu, Salih Sertaç Durusoy, Hüseyin Derya Dinçyürek, Emin Kaya, Elif Gülsüm Ümit, İrfan Yavaşoğlu, Özgür Mehtap, Burak Deveci, Mehmet Ali Özcan, Hatice Terzi, Müfide Okay, Nilgün Sayınalp, Mehmet Yılmaz, Vahap Okan, Alperen Kızıklı, Ömer Özcan, Güven Çetin, Sinan Demircioğlu, İsmet Aydoğdu, Güray Saydam, Eren Arslan Davulcu, Gül İlhan, Mehmet Ali Uçar, Gülsüm Özet, Seval Akpınar, Burhan Turgut, İlhami Berber, Erdal Kurtoğlu, Mehmet Sönmez, Derya Selim Batur, Rahşan Yıldırım, Vildan Özkocaman, Ahmet Kürşad Güneş, Birsen Sahip, Şehmus Ertop, Olga Meltem Akay, Abdülkadir Baştürk, Mehmet Hilmi Doğu, Aydan Akdeniz, Ali Ünal, Ahmet Seyhanlı, Emel Gürkan, Demet Çekdemir, Burhan Ferhanoğlu
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 4, Pp 273-285 (2021)
Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients (mean age +- standard deviat
Externí odkaz:
https://doaj.org/article/506b9a34c2d64dd5beb096f766347808
Autor:
Demet Çekdemir, Mehmet Gunduz
Publikováno v:
Sakarya Tıp Dergisi, Vol 10, Iss 1, Pp 107-112 (2020)
Objective: To evaluate retrospectively the efficacy of treatment in chronic myeloid leukemia (CML) patients followed up in our center and receiving imatinib treatment.Materials and Methods: Eighty-five chronic phase CML patients with adequate clinica
Externí odkaz:
https://doaj.org/article/a6c97ad48adb4b09823d0e3f078de1d2
Autor:
Duygu Koca, Nurcan Haştar, Selin Engür, Yağmur Kiraz, Gizem Tuğçe Ulu, Demet Çekdemir, Yusuf Baran
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 1, Pp 5-12 (2020)
Objective: Acute myeloid leukemia (AML) is a complex disease affected by both genetic and epigenetic factors. Histone methylation and demethylation are types of epigenetic modification in chromatin remodeling and gene expression. Abnormal expression
Externí odkaz:
https://doaj.org/article/4247402beef34fc4a6ebf9b1dd7849c0
Autor:
Ajanthah Sangaralingam, John G. Gribben, Shahryar Kiaii, Sameena Iqbal, Alan G. Ramsay, John Riches, Tracy Chaplin, Demet Cekdemir
Publikováno v:
Blood. 118:976-976
Abstract 976 Lenalidomide has recently been demonstrated to have significant activity in chronic lymphocytic leukemia (CLL). Its mechanism of action in this disease is not well understood, but it is thought to act primarily by enhancing anti-tumor im